{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:02:58Z","timestamp":1784894578754,"version":"3.55.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.arcmed.2026.103492","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:00:53Z","timestamp":1784890853000},"page":"103492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variant Curation and Classification in Rare Disease Genomics: Standards and Emerging Tools for Single-Nucleotide Variant Analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Jimena","family":"Barraza Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-2751","authenticated-orcid":false,"given":"Marta","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1262-5709","authenticated-orcid":false,"given":"Leire","family":"Echepare Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Iv\u00e1n","family":"Rivera Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"del Nogal Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2026.103492_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0002","article-title":"Artificial Intelligence: A New Frontier in Rare Disease Early Diagnosis","volume":"17","author":"Nishat","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.arcmed.2026.103492_bib0003","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13023-025-03655-x","article-title":"Applying artificial intelligence to rare diseases: a literature review highlighting lessons from fabry disease","volume":"20","author":"Germain","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.arcmed.2026.103492_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1169109","article-title":"Resources and tools for rare disease variant interpretation","volume":"10","author":"Licata","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.arcmed.2026.103492_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","article-title":"How many rare diseases are there?","volume":"19","author":"Haendel","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arcmed.2026.103492_bib0006","unstructured":"Food and Drug Administration. Orphan Drug Act Public Law 97-414. Approved January 4, 1983. Last updated August 2013. https:\/\/www.fda.gov\/industry\/designating-orphan-product-drugs-and-biological-products\/orphan-drug-act-relevant-excerpts. (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0007","unstructured":"EC: (European Commission). Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A02000R0141-20190726. (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0008","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.medcli.2021.10.006","article-title":"Rare diseases in Spain: a look into the future","volume":"158","author":"Riera-Mestre","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.arcmed.2026.103492_bib0009","article-title":"First Year Results and Insights from the Mexican Rare Disease Patient Registry","volume":"2","author":"Aspiros","year":"2024","journal-title":"Rare"},{"key":"10.1016\/j.arcmed.2026.103492_bib0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(08)61393-8","article-title":"35 years of Japanese policy on rare diseases","volume":"372","author":"Hayashi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0011","unstructured":"European Commission. Rare diseases and European reference networks. https:\/\/health.ec.europa.eu\/rare-diseases-and-european-reference-networks\/rare-diseases_en. (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0012","first-page":"28","article-title":"Evaluating seven bioinformatics platforms for tertiary analysis of genomic data from whole exome sequencing in a pilot group of patients","volume":"6","author":"Bastida-Lertxundi","year":"2025","journal-title":"Adv Lab Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0013","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00439-025-02732-2","article-title":"Critical assessment of missense variant effect predictors on disease-relevant variant data","volume":"144","author":"Rastogi","year":"2025","journal-title":"Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0014","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/jpm14080864","article-title":"Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis","volume":"14","author":"Lazareva","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0015","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41588-024-01842-3","article-title":"Guidance for estimating penetrance of monogenic disease-causing variants in population cohorts","volume":"56","author":"Wright","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.44526","article-title":"Clinical Variant Reclassification in Hereditary Disease Genetic Testing","volume":"7","author":"Kobayashi","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arcmed.2026.103492_bib0017","article-title":"Evidence Aggregator: AI reasoning applied to rare disease diagnostics","author":"Twede","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120065","article-title":"Study of the impact of ClinGen Revisions on ACMG\/AMP variant semi-automatic classification for Rare Diseases diagnosis","volume":"566","author":"Rius","year":"2025","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2026.103492_bib0019","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/bfgp\/elv054","article-title":"Exome sequencing explained: a practical guide to its clinical application","volume":"15","author":"Seaby","year":"2016","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.arcmed.2026.103492_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4955235","article-title":"Reasons and Resolutions for Inconsistent Variant Interpretation","volume":"2023","author":"Lin","year":"2023","journal-title":"Hum Mutat"},{"key":"10.1016\/j.arcmed.2026.103492_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101398","article-title":"A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic diseases","volume":"27","author":"Pandey","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40246-024-00604-w","article-title":"Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project","volume":"18","author":"Stenton","year":"2024","journal-title":"Hum Genomics"},{"key":"10.1016\/j.arcmed.2026.103492_bib0023","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa2314761","article-title":"Genome Sequencing for Diagnosing Rare Diseases","volume":"390","author":"Wojcik","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41525-024-00455-3","article-title":"Exome sequencing of 18,994 ethnically diverse patients with suspected rare Mendelian disorders","volume":"10","author":"Han","year":"2025","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53514","article-title":"Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders","volume":"7","author":"Nurchis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arcmed.2026.103492_bib0026","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12920-024-01795-w","article-title":"Whole genome sequencing in clinical practice","volume":"17","author":"Bagger","year":"2024","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.arcmed.2026.103492_bib0027","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1101\/gr.279970.124","article-title":"The additional diagnostic yield of long-read sequencing in undiagnosed rare diseases","volume":"35","author":"Del Gobbo","year":"2025","journal-title":"Genome Res"},{"key":"10.1016\/j.arcmed.2026.103492_bib0028","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Manickam","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0029","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/jmg-2024-110228","article-title":"Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access","volume":"61","author":"Ellard","year":"2024","journal-title":"J Med Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s44342-024-00032-1","article-title":"Rare disease genomics and precision medicine","volume":"22","author":"Hong","year":"2024","journal-title":"Genomics Inform"},{"key":"10.1016\/j.arcmed.2026.103492_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101447","article-title":"Improved diagnosis of patients with rare diseases through the application of constrained coding region annotation and de novo status","volume":"27","author":"Odhams","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0032","article-title":"Improvement of variant reclassification in genetic neurodevelopmental conditions","volume":"2","author":"Kowanda","year":"2024","journal-title":"Genet Med Open"},{"key":"10.1016\/j.arcmed.2026.103492_bib0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2023.11.005","article-title":"Will variants of uncertain significance still exist in 2030?","volume":"111","author":"Fowler","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0034","article-title":"The impact of systematized generation, evaluation, and incorporation of machine learning algorithms for clinical variant classification","author":"Fresard","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-023-01191-6","article-title":"Clinical utility of periodic reinterpretation of CNVs of uncertain significance: an 8-year retrospective study","volume":"15","author":"Ravel","year":"2023","journal-title":"Genome Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0036","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jmg-2023-109488","article-title":"Variant reclassification and clinical implications","volume":"61","author":"Walsh","year":"2024","journal-title":"J Med Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0037","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00125817-200009000-00009","article-title":"ACMG recommendations for standards for interpretation of sequence variations","volume":"2","author":"Kazazian","year":"2000","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0038","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0039","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0040","unstructured":"ACGS best practice guidelines for variant classification in rare disease 2024. https:\/\/www.acgs.uk.com\/media\/12533\/uk-practice-guidelines-for-variant-classification-v12-2024.pdf (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0041","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-021-00903-z","article-title":"Stepwise ABC system for classification of any type of genetic variant","volume":"30","author":"Houge","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0042","article-title":"Calibration and refinement of ACMG\/AMP criteria for variant classification with BayesQuantify","author":"Liu","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0043","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41431-024-01617-8","article-title":"Comparison of the ABC and ACMG systems for variant classification","volume":"32","author":"Houge","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0044","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/gim.2017.210","article-title":"Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework","volume":"20","author":"Tavtigian","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0045","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/humu.24088","article-title":"Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines","volume":"41","author":"Tavtigian","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.arcmed.2026.103492_bib0046","unstructured":"American College of Medical Genetics and Genomics. Documents in Development. https:\/\/www.acmg.net\/ACMG\/Medical-Genetics-Practice-Resources\/Documents_in_Development.aspx (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0047","unstructured":"Clinical Genome Resource. ClinGen Summer Workshop Series 2023. https:\/\/clinicalgenome.org\/tools\/clingen-summer-workshop-series-2023\/sept-15-2023\/ (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0048","unstructured":"ACMG 2025 Annual Meeting Conference Programme. https:\/\/www.acmgmeeting.net\/conference-program\/acmg-cap-clingen-standards-sequence-variant-classification (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0049","unstructured":"Zifo. ACMG v4 Draft Preview. https:\/\/zifornd.com\/blogs\/acmg-v4-draft-preview-transformative-changes-in-variant-classification\/ (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0050","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","article-title":"Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium","volume":"98","author":"Amendola","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0051","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajhg.2020.09.011","article-title":"Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies","volume":"107","author":"Amendola","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0052","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/gim.2017.60","article-title":"Sources of discordance among germ-line variant classifications in ClinVar","volume":"19","author":"Yang","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0053","article-title":"Tracking updates in clinical databases increases efficiency for variant reanalysis","volume":"2","author":"Li","year":"2024","journal-title":"Genet Med Open"},{"key":"10.1016\/j.arcmed.2026.103492_bib0054","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13059-025-03572-z","article-title":"Guidelines for releasing a variant effect predictor","volume":"26","author":"Livesey","year":"2025","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103492_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101400","article-title":"Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level","volume":"27","author":"Bennett","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0056","article-title":"Benchmarking of variant pathogenicity prediction methods using a population genetics approach","author":"Gudkov","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0057","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41525-025-00480-w","article-title":"Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort","volume":"10","author":"Kong","year":"2025","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0058","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13059-023-03113-6","article-title":"CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods","volume":"25","year":"2024","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103492_bib0059","article-title":"Toward Automatic Variant Interpretation: Discordant Genetic Interpretation Across Variant Annotations for ClinVar Pathogenic Variants","author":"Chen","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101304","article-title":"Estimation of carrier frequencies of autosomal and X-linked recessive genetic conditions based on gnomAD v4.0 data in different ancestries","volume":"27","author":"Hotakainen","year":"2025","journal-title":"Genet Med."},{"key":"10.1016\/j.arcmed.2026.103492_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101413","article-title":"Unique signatures of highly constrained genes across publicly available genomic databases","volume":"27","author":"Schmitz-Abe","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0062","article-title":"Improved Allele Frequencies in gnomAD through Local Ancestry Inference","author":"Kore","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0063","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2026.103492_bib0064","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2026.103492_bib0065","article-title":"Overview of specifications to the ACMG\/AMP variant interpretation guidelines","volume":"103","author":"Harrison","year":"2019","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0066","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0067","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0068","article-title":"The All of Us Research Program: Data quality, utility, and diversity","volume":"3","author":"Ramirez","year":"2022","journal-title":"Patterns (NY)"},{"key":"10.1016\/j.arcmed.2026.103492_bib0069","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ajhg.2024.07.023","article-title":"All of Us Research Program year in review: 2023\u20132024","volume":"111","author":"Kozlowski","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0070","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1038\/s41467-025-59351-8","article-title":"Genetic ancestry and population structure in the All of Us Research Program cohort","volume":"16","author":"Sharma","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2026.103492_bib0071","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-024-07556-0","article-title":"A deep catalogue of protein-coding variation in 983,578 individuals","volume":"631","author":"Sun","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2026.103492_bib0072","article-title":"The Impact of Clinical and Molecular Variant Properties on Calibration and Performance of Variant Effect Prediction Tools","author":"Isakov","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2025.111036","article-title":"Insights for variant clinical interpretation based on a benchmark of 65 variant effect predictors","volume":"117","author":"Radjasandirane","year":"2025","journal-title":"Genomics"},{"key":"10.1016\/j.arcmed.2026.103492_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101402","article-title":"Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3\/BP4 criteria","volume":"27","author":"Bergquist","year":"2025","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0075","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"775 of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101213","article-title":"Assessment of the evidence yield for the calibrated PP3\/BP4 computational recommendations","volume":"26","author":"Stenton","year":"2024","journal-title":"Genet Med"},{"issue":"26","key":"10.1016\/j.arcmed.2026.103492_bib0077","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13059-025-03647-x","article-title":"Mapping MAVE data for use in human genomics applications","volume":"25","author":"Arbesfeld","year":"2025","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103492_bib0078","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13059-025-03575-w","article-title":"Variant effect predictor correlation with functional assays is reflective of clinical classification performance","volume":"26","author":"Livesey","year":"2025","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103492_bib0079","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13059-025-03476-y","article-title":"MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assays","volume":"26","author":"Rubin","year":"2025","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103492_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411872","article-title":"Choosing Variant Interpretation Tools for Clinical Applications: Context Matters","volume":"24","author":"Aguirre","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2026.103492_bib0081","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41525-023-00386-5","article-title":"Characterizing the pathogenicity of genetic variants: the consequences of context","volume":"9","author":"Ciesielski","year":"2024","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0082","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13059-023-02986-x","article-title":"An Atlas of Variant Effects to understand the genome at nucleotide resolution","volume":"24","author":"Fowler","year":"2023","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2026.103492_bib0083","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","article-title":"ClinGen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification","volume":"111","author":"Biesecker","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0084","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1086\/301871","article-title":"Missense mutations in disease genes: a Bayesian approach to evaluate causality","volume":"62","author":"Petersen","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/378100","article-title":"A full-likelihood method for the evaluation of causality of sequence variants from family data","volume":"73","author":"Thompson","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0086","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ajhg.2016.04.003","article-title":"Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants","volume":"98","author":"Jarvik","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0087","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41436-020-0920-4","article-title":"Considerations in assessing germline variant pathogenicity using cosegregation analysis","volume":"22","author":"Belman","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0088","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10689-017-0017-7","article-title":"A comparison of cosegregation analysis methods for the clinical setting","volume":"17","author":"Ra\u00f1ola","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.arcmed.2026.103492_bib0089","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/humu.24363","article-title":"An algorithm for optimal testing in co-segregation analysis","volume":"43","author":"Buie","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.arcmed.2026.103492_bib0090","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae201","article-title":"shinyseg: a web application for flexible cosegregation and sensitivity analysis","volume":"40","author":"Carrizosa","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.arcmed.2026.103492_bib0091","first-page":"115","article-title":"The future role of facial image analysis in ACMG classification guidelines","volume":"35","author":"Lesmann","year":"2023","journal-title":"Med Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.32061","article-title":"Computational facial analysis for rare Mendelian disorders","volume":"193","author":"Hsieh","year":"2023","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0093","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02020","article-title":"Diagnostically relevant facial gestalt information from ordinary photos","volume":"3","author":"Ferry","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.arcmed.2026.103492_bib0094","doi-asserted-by":"crossref","DOI":"10.2196\/19263","article-title":"Efficiency of computer-aided facial phenotyping (DeepGestalt) in individuals with and without a genetic syndrome: diagnostic accuracy study","volume":"22","author":"Pantel","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.arcmed.2026.103492_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-021-01010-x","article-title":"GestaltMatcher facilitates rare disease matching using facial phenotype descriptors","volume":"54","author":"Hsieh","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0096","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41588-023-01469-w","article-title":"PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework","volume":"55","author":"Dingemans","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0097","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41591-024-03420-w","article-title":"Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses","volume":"31","author":"Laurie","year":"2025","journal-title":"Nat Med"},{"issue":"Database issue","key":"10.1016\/j.arcmed.2026.103492_bib0098","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2026.103492_bib0099","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.1167363","article-title":"GENETICS. The Human Variome Project","volume":"322","author":"Cotton","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.arcmed.2026.103492_bib0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13104-015-1798-0","article-title":"Harmonizing the interpretation of genetic variants across the world: the Malaysian experience","volume":"9","author":"Hassan","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.arcmed.2026.103492_bib0101","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41431-021-00959-x","article-title":"The LOVD3 platform: efficient genome-wide sharing of genetic variants","volume":"29","author":"Fokkema","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0102","unstructured":"UK Department of Health and Social Care. England Rare Diseases Action Plan 2025: Main Report. GOV.UK. https:\/\/www.gov.uk\/government\/publications\/england-rare-diseases-action-plan-2025\/england-rare-diseases-action-plan-2025-main-report (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0103","article-title":"ClinGen Consortium. The Clinical Genome Resource (ClinGen): Advancing genomic knowledge through global curation","volume":"27","year":"2025","journal-title":"Genet Med."},{"key":"10.1016\/j.arcmed.2026.103492_bib0104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-genom-102822-100509","article-title":"DECIPHER: Improving Genetic Diagnosis Through Dynamic Integration of Genomic and Clinical Data","volume":"24","author":"Foreman","year":"2023","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0105","unstructured":"GenQA. GENie: Genomic Education and Assessment. https:\/\/genqa.org\/genie\/ (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0106","unstructured":"Wellcome Connecting Science. Genomic interpretation courses. https:\/\/coursesandconferences.wellcomeconnectingscience.org\/ (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0107","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jgc4.1837","article-title":"Massive open online courses (MOOCs) in genomic variant interpretation: An innovative education strategy for the growing genetic counselor workforce","volume":"33","author":"Coad","year":"2024","journal-title":"J Genet Couns."},{"key":"10.1016\/j.arcmed.2026.103492_bib0108","unstructured":"CanVIG-UK Consensus Specification for Cancer Susceptibility Genes (CSGs) of ACGS Best Practice Guidelines for Variant Classification 2024 v3.00. https:\/\/www.cangene-canvaruk.org\/_files\/ugd\/ed948a_ca951fe798294f7f8545d99ec0909e35.pdf (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0109","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.arcmed.2026.103492_bib0110","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","article-title":"Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup","volume":"110","author":"Walker","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2026.103492_bib0111","unstructured":"ClinGen Sequence Variant Interpretation Recommendation for de novo Criteria (PS2\/PM6) - Version 1.1 https:\/\/clinicalgenome.org\/site\/assets\/files\/3461\/svi_proposal_for_de_novo_criteria_v1_1.pdf. (Accessed June 15, 2025)."},{"issue":"12","key":"10.1016\/j.arcmed.2026.103492_bib0112","first-page":"3","article-title":"Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework","volume":"31","author":"Brnich","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0113","unstructured":"SVI Recommendation for Absence\/Rarity (PM2) - Version 1.0. https:\/\/clinicalgenome.org\/site\/assets\/files\/5182\/pm2_-_svi_recommendation_-_approved_sept2020.pdf (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0114","unstructured":"ClinGen SVI Recommendation for in trans Criterion (PM3) - Version 1.0 https:\/\/clinicalgenome.org\/site\/assets\/files\/3717\/svi_proposal_for_pm3_criterion_-_version_1.pdf (Accessed June 15, 2025)."},{"key":"10.1016\/j.arcmed.2026.103492_bib0115","article-title":"A Comprehensive and Accessible Model for Co-Segregation Analysis in BRCA1, BRCA2, and PALB2 Variant Classification","author":"Moghadasi","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.arcmed.2026.103492_bib0116","first-page":"1030","article-title":"MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains","volume":"40","author":"Wiel","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1016\/j.arcmed.2026.103492_bib0117","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/gim.2018.42","article-title":"The ACMG\/AMP reputable source criteria for the interpretation of sequence variants","volume":"20","author":"Biesecker","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2026.103492_bib0118","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/humu.23642","article-title":"Updated recommendation for the benign stand-alone ACMG\/AMP criterion","volume":"39","author":"Ghosh","year":"2018","journal-title":"Hum Mutat"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440926001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:33:09Z","timestamp":1784892789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440926001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0188440926001141"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103492","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variant Curation and Classification in Rare Disease Genomics: Standards and Emerging Tools for Single-Nucleotide Variant Analysis","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2026.103492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103492"}}